|  Help  |  About  |  Contact Us

Publication : Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.

First Author  Wang GY Year  2017
Journal  Oncogene Volume  36
Issue  26 Pages  3772-3780
PubMed ID  28263978 Mgi Jnum  J:243369
Mgi Id  MGI:5908309 Doi  10.1038/onc.2017.12
Citation  Wang GY, et al. (2017) Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression. Oncogene 36(26):3772-3780
abstractText  Human basal cell carcinomas (BCCs) very frequently carry p53 mutations, and p53 loss markedly accelerates murine BCC carcinogenesis. We report here our studies of the mechanism by which p53 is activated to suppress BCC carcinogenesis. We find that aberrant hedgehog signaling in microscopic BCCs activates p53 in part via Arf (that is, the oncogene-induced stress pathway) but not via the DNA damage response pathway. However, Arf loss and p53 loss produce differing outcomes-loss of p53 promotes both tumor initiation and progression; loss of Arf promotes tumor progression but not initiation. Intriguingly, increased expression of Arf in tumor stromal cells, as in tumor keratinocytes themselves, contributes to suppression of BCC carcinogenesis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

13 Bio Entities

Trail: Publication

0 Expression